Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
02/15/2006 | CN1733071A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
02/15/2006 | CN1733070A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
02/15/2006 | CN1733069A Oral cavity spray containing two effective parts of compound red sage root formula and its preparation process |
02/15/2006 | CN1733068A Chinese medicinal preparation for promoting blood circulation, dissipating blood stasis, inducing reuscitation with aromatics and preparation process thereof |
02/15/2006 | CN1733066A Medicinal composition containing red sage root extract and its application in preparation of medicine for preventing or treating cardiovascular and cerebrovascular disease |
02/15/2006 | CN1733064A Pain stopping ointment for piles |
02/15/2006 | CN1733061A Chinese medicinal preparation with astragalus root and erigeron breviscapus and application thereof |
02/15/2006 | CN1733060A Usage of asiabell and astragalus root composition in decrease of platelet aggregation |
02/15/2006 | CN1733059A Cardiovascular and cerebrovascular disease treating medicine |
02/15/2006 | CN1733049A Soft capsule for treating heart palpitation and its preparation method |
02/15/2006 | CN1733046A Externally used medicine bag for treating piles and preparation method thereof |
02/15/2006 | CN1733039A Compound preparation of breviscapinum for treating cardiovascular and cerebrovascular diseases and its preparing process |
02/15/2006 | CN1733037A Chinese medicinal preparation for treating cardiovascular diseases and its preparing process |
02/15/2006 | CN1733036A Dripping pills for dredging thrombus and preparation process thereof |
02/15/2006 | CN1733031A Brain caring oral liquid and its preparation process |
02/15/2006 | CN1733030A Chest discomfort treating oral liquid and preparation process thereof |
02/15/2006 | CN1733029A Chinese medicinal composition with bilateral functions for treating angina pectoris and/or arrhythmia |
02/15/2006 | CN1733023A Red rice and gingko leaf composition for preventing and treating cardiovascular and cerebrovascular disease and its application |
02/15/2006 | CN1733019A Medicine for treating cardiovascular and cerebrovascular disease |
02/15/2006 | CN1733013A Novel route for administering hairy holly injection and preparation process thereof |
02/15/2006 | CN1732994A Medical caring product for piles and preparation process thereof |
02/15/2006 | CN1732989A Miao ethnic medicine for treating piles and its preparing process |
02/15/2006 | CN1732974A Medicinal composition of fructose diphosphate sodium and magnesium salt |
02/15/2006 | CN1732972A Dextran for injection and method for preparing the same |
02/15/2006 | CN1732970A Breviscapine injection liquid and its preparing process |
02/15/2006 | CN1732966A Dispersible tablet of puerarin and its preparation process |
02/15/2006 | CN1732964A Pharmaceutical composition, its preparation process and usage |
02/15/2006 | CN1732954A Freeze dry emulsion of prostaglandin for injection and method for preparing the same |
02/15/2006 | CN1732953A Dispersible tablet for treating hypertension |
02/15/2006 | CN1732952A Compound dispersible tablet for treating hypertension |
02/15/2006 | CN1732936A Nimodipine emulsion injection liquid and method for preparing the same |
02/15/2006 | CN1732935A Compound orally administered formulation of Carvedilol and manidipine |
02/15/2006 | CN1732934A Freeze dry betahistine hydrochloride injection and method for preparing the same |
02/15/2006 | CN1732923A Ligustilide cyclodextrin or its derivatives clathrate, its preparation method and pharmaceutical formulation |
02/15/2006 | CN1732921A Application of ligustilide in preparation of medicine for preventing and treating cerebral ischemia diseases |
02/15/2006 | CN1732915A Tanshinone IIA infusion solution and its preparation method |
02/15/2006 | CN1732913A Propylgallate injection liquid with favorable stability and its preparation process |
02/15/2006 | CN1732908A Borneol contained spray |
02/15/2006 | CN1732904A Externally applied powder |
02/15/2006 | CN1241932C Novel oligosaccharides, preparation method and pharmaceutical composition containing same |
02/15/2006 | CN1241921C Fluoro isoflavone containing derivative, monufacturing method and its use |
02/15/2006 | CN1241915C Prepn process and use of substituted pyrazole compound |
02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
02/15/2006 | CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
02/15/2006 | CN1241632C Chinese patent medicine for treating cardiac function failure and its preparation method |
02/15/2006 | CN1241612C Medicine for treating paralysis disease |
02/15/2006 | CN1241611C Medicine for treating hypertension and its preparing process |
02/15/2006 | CN1241602C Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases |
02/15/2006 | CN1241593C Compound of Chinese traditional medicine in use for acute stage of apoplexy of cerebral cerebral ischemia |
02/15/2006 | CN1241592C Medicinal liquor for bringing high blood pressure down and preparing process thereof |
02/15/2006 | CN1241588C Fructus choerospondiatis freeze-drying powder injection and its preparing method |
02/15/2006 | CN1241584C Chinese proprietary medicine for treating coronary heart disease and angina pectoris |
02/15/2006 | CN1241583C Fermented soybean extracted liquid and composite medicine containing the said liquid |
02/15/2006 | CN1241577C Medicine use of cyclodextrin derivatives and medicine composition thereof |
02/15/2006 | CN1241575C Cell growth regulating factor U and its preparation process |
02/15/2006 | CN1241566C Cilostazol solid dispersion and its method for preparing tablet |
02/15/2006 | CN1241563C Application of Jigansan extract in preparation of medicine for treating angiocardiopathy |
02/15/2006 | CN1241558C Atenolol guttate pill and method for preparing the same |
02/15/2006 | CN1241554C Medicinal composition for treating hypertension and preparing method thereof |
02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
02/14/2006 | US6998412 Heterocyclic compounds |
02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
02/14/2006 | US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
02/14/2006 | US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
02/14/2006 | US6998398 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs |
02/14/2006 | US6998395 Controlled release formulation for preventing or treating risk factors for cardiovascular disease |
02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
02/14/2006 | US6998254 Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis |
02/14/2006 | US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
02/14/2006 | US6997865 Cardiac support device with anti-fibrosis lining |
02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
02/11/2006 | CA2515754A1 Kit for dip coating medical devices comprising an aqueous latex polymeric emulsion |
02/09/2006 | WO2006015124A2 Fused ring heterocycle kinase modulators |
02/09/2006 | WO2006014864A2 Methods and compositions for reducing c-reactive protein |
02/09/2006 | WO2006014005A1 Pyrazole derivative |
02/09/2006 | WO2006013948A1 Triazole derivative |
02/09/2006 | WO2002088316A3 G-protein coupled receptors |
02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
02/09/2006 | US20060030614 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C |
02/09/2006 | US20060030605 Pharmaceutical compounds |
02/09/2006 | US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases |
02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
02/09/2006 | US20060030004 Solid phase synthesis |
02/09/2006 | US20060029990 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
02/09/2006 | US20060029605 Use of ErbB receptor ligands in treating diabetes |
02/09/2006 | US20060029592 Methods of treating peripheral arterial occlusions |